The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania
Open accessThe DOI matches its Crossref record; 257 of the 257 references it cites were found in a registry or an index.
Abstract
These updated guidelines are based on a first edition that was published in 2003, and have been edited and updated with the available scientific evidence until end of 2008. Their purpose is to supply a systematic overview of all scientific evidence pertaining to the treatment of acute mania in adults. The data used for these guidelines have been extracted from a MEDLINE and EMBASE search, from the clinical trial database clinicaltrials.gov, from recent proceedings of key conferences, and from various national and international treatment guidelines. Their scientific rigor was categorised into six levels of evidence (A-F). As these guidelines are intended for clinical use, the scientific evidence was finally asigned different grades of recommendation to ensure practicability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744 · cited 2×
“Large placebo-controlled studies include subjects with a variety of severity grades of mania above a predefined threshold (usually a YMRS (Young et al. 1978) score of ]20 or a SADS-C derived Mania Rating Scale (MRS) (Endicott and Spitzer 1978) of ]14 in monotherapy studies; in adjunctive,…”
BackgroundEffectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia
Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., Keefe, R. S. E., Davis, S. M., Davis, C. E., Lebowitz, B. D., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051688 · Cited by 5,892
A Diagnostic Interview: The Schedule for Affective Disorders and Schizophrenia
Endicott, J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310043002 · Cited by 5,684
(1984) · The Lancet · doi:10.1016/s0140-6736(84)92810-1 · Cited by 2,925
Merikangas, K. R., Akiskal, H. S., Angst, J., Greenberg, P. E., Hirschfeld, R. M. A., Petukhova, M., & Kessler, R. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.5.543 · Cited by 2,399
Cross-national epidemiology of major depression and bipolar disorder
Weissman, M. M. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540040037030 · Cited by 2,302
Pharmaceutical industry sponsorship and research outcome and quality: systematic review
Lexchin, J., Bero, L. A., Djulbegovic, B., & Clark, O. (2003) · BMJ · doi:10.1136/bmj.326.7400.1167 · Cited by 2,147 · cited 1×
“Another methodological limitation is sponsor bias (Lexchin et al. 2003; Perlis et al. 2005; Heres et al. 2006; Lexchin and Light 2006) inherent in most single studies on which the guidelines are based.”
BackgroundAtypical antipsychotic drugs and the risk of sudden cardiac death
Ray, W. A., Chung, C. P., Murray, K. T., Hall, K., & Stein, C. M. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806994 · Cited by 1,194 · cited 1×
“The primary salience of the metabolic syndrome derives from its links to cardiovascular risk factors, and the attendant mortality risks of longterm treatment with atypical agents (Ray et al. 2009).”
BackgroundGeddes, J., Freemantle, N., Harrison, P., & Bebbington, P. (2000) · BMJ · doi:10.1136/bmj.321.7273.1371 · Cited by 1,062
National Collaborating Centre for Mental Health
Veale, D. M. (2006) · Research Portal (King's College London) · Cited by 941
Tohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1079 · Cited by 908
Self-citationCalabrese, J. R., Keck, P. E., Macfadden, W., Minkwitz, M., Ketter, T. A., Weisler, R. H., Cutler, A. J., McCoy, R., Wilson, E., Mullen, J., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.7.1351 · Cited by 883 · cited 3×
“…Akathisia and the Simpson Angus Rating Scale for Parkinsonism, but (as was the case for olanzapine) no significant differences between quetiapine, placebo or the comparator drugs in all trials with respect to EPS were observed (Bowden et al. 2005; Calabrese et al. 2005; McIntyre et al. 2005).”
BackgroundMethodMorrow, J. (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.074203 · Cited by 880
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Self-citationThe double-blind, randomized, placebo-controlled trial
Kaptchuk, T. J. (2001) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00347-4 · Cited by 595
Olanzapine versus placebo in the treatment of acute mania
Tohen, M., Sanger, T. M., McElroy, S. L., Tollefson, G. D., Chengappa, K. N. R., Daniel, D. G., Petty, F., Centorrino, F., Wang, R., Grundy, S. L., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.5.702 · Cited by 585
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.12.1 · Cited by 583
THE TREATMENT OF MANIC PSYCHOSES BY THE ADMINISTRATION OF LITHIUM SALTS
Schou, M., Juel-Nielsen, N., Stromgren, E., & Voldby, H. (1954) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.17.4.250 · Cited by 552
Tohen, M. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.9.841 · Cited by 539
Tohen, M., Frank, E., Bowden, C. L., Colom, F., Ghaemi, S. N., Yatham, L. N., Malhi, G. S., Calabrese, J. R., Nolen, W. A., Vieta, E., et al. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00726.x · Cited by 513
Self-citationKeck, P. E., Marcus, R., Tourkodimitris, S., Ali, M., Liebeskind, A., Saha, A., Ingenito, G., & Aripiprazole Study Group (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1651 · Cited by 501
Carbamazepine in manic-depressive illness: a new treatment
(1980) · American Journal of Psychiatry · doi:10.1176/ajp.137.7.782 · Cited by 484
The McLean-Harvard First-Episode Mania Study: Prediction of Recovery and First Recurrence
Tohen, M., Zarate, C. A., Hennen, J., Khalsa, H.-M. K., Strakowski, S. M., Gebre-Medhin, P., Salvatore, P., & Baldessarini, R. J. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.12.2099 · Cited by 471
Tohen, M., Chengappa, K. N. R., Suppes, T., Zarate, C. A., Calabrese, J. R., Bowden, C. L., Sachs, G. S., Kupfer, D. J., Baker, R. W., Risser, R. C., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.1.62 · Cited by 463
Self-citationValproatereatment of Acute Mania: A Placebo-Controlled
Pope, H. G. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810250064008 · Cited by 460
Heres, S., Davis, J., Maino, K., Jetzinger, E., Kissling, W., & Leucht, S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.185 · Cited by 450
DELBELLO, M. P., SCHWIERS, M. L., ROSENBERG, H. L., & STRAKOWSKI, S. M. (2002) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200210000-00011 · Cited by 443
Sachs, G. S., Grossman, F., Ghaemi, S. N., Okamoto, A., & Bowden, C. L. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.7.1146 · Cited by 424 · cited 11×
“In line with this clinical practice are observations from randomized, controlled trials that addition of an antipsychotic drug to patients with persistent manic symptoms despite treatment with lithium or valproate has shown greater rates of acute efficacy than has continuation of lithium or valproate alone (Tohen et a…”
BackgroundResultInfluentialSelf-citationThe AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry
Baumann, P., Hiemke, C., Ulrich, S., Eckermann, G., Gaertner, I., Gerlach, M., Kuss, H.-J., Laux, G., Müller-Oerlinghausen, B., Rao, M. L., et al. (2004) · Pharmacopsychiatry · doi:10.1055/s-2004-832687 · Cited by 419
Electroconvulsive therapy of acute manic episodes: a review of 50 years' experience
(1994) · American Journal of Psychiatry · doi:10.1176/ajp.151.2.169 · Cited by 396
Bowden, C. L., Grunze, H., Mullen, J., Brecher, M., Paulsson, B., Jones, M., Vågerö, M., & Svensson, K. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0116 · Cited by 376
Self-citationDepression During Mania: Treatment Response to Lithium or Divalproex
Swann, A. C. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830130041008 · Cited by 374
Keck, P. E., Versiani, M., Potkin, S., West, S. A., Giller, E., Ice, K., & the Ziprasidone in Mania Study Group (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.4.741 · Cited by 369
Gelenberg, A. J. (1985) · Psychosomatics · doi:10.1016/s0033-3182(85)72762-4 · Cited by 363
Weisler, R. H., Kalali, A. H., Ketter, T. A., & SPD417 Study Group (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0405 · Cited by 350
The AGNP-TDM Expert Group Consensus Guidelines: Therapeutic Drug Monitoring in Psychiatry
Gaertner, I., Baumann, P., Hiemke, C., Ulrich, S., Eckermann, G., Gerlach, M., Kuss, H., Laux, G., Müller-Oerlinghausen, B., Rao, M., et al. (2005) · Pharmacopsychiatry · doi:10.1055/s-2005-862645 · Cited by 343
Tohen, M., Ketter, T. A., Zarate, C. A., Suppes, T., Frye, M., Altshuler, L., Zajecka, J., Schuh, L. M., Risser, R. C., Brown, E., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.7.1263 · Cited by 342
Clinically Significant Pharmacokinetic Drug Interactions with Carbamazepine: An Update
Spina, E., Pisani, F., & Perucca, E. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199631030-00004 · Cited by 331
Risk for Bipolar Illness in Patients Initially Hospitalized for Unipolar Depression
Goldberg, J. F., Harrow, M., & Whiteside, J. E. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1265 · Cited by 319
Perlis, R. H., Perlis, C. S., Wu, Y., Hwang, C., Joseph, M., & Nierenberg, A. A. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1957 · Cited by 318 · cited 1×
“Another methodological limitation is sponsor bias (Lexchin et al. 2003; Perlis et al. 2005; Heres et al. 2006; Lexchin and Light 2006) inherent in most single studies on which the guidelines are based.”
BackgroundTohen, M., Calabrese, J. R., Sachs, G. S., Banov, M. D., Detke, H. C., Risser, R., Baker, R. W., Chou, J. C.-Y., & Bowden, C. L. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.247 · Cited by 317 · cited 2×
“Persistence of subsyndromal mania is associated with a significantly increased risk of relapse (Tohen et al. 2003d, 2006a).”
BackgroundSelf-citationOlanzapine Versus Placebo in the Treatment of Adolescents With Bipolar Mania
Tohen, M., Kryzhanovskaya, L., Carlson, G., DelBello, M., Wozniak, J., Kowatch, R., Wagner, K., Findling, R., Lin, D., Robertson-Plouch, C., et al. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111932 · Cited by 315
Gabapentin in bipolar disorder: a placebo‐controlled trial of adjunctive therapy1
Pande, A. C., Crockatt, J. G., Janney, C. A., Werth, J. L., Tsaroucha, G., & Gabapentin Bipolar Disorder Study Group (2000) · Bipolar Disorders · doi:10.1034/j.1399-5618.2000.20305.x · Cited by 313
A double-blind comparison of valproate and lithium in the treatment of acute mania
(1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.1.108 · Cited by 301
Keck, P. E., Calabrese, J. R., McQuade, R. D., Carson, W. H., Carlson, B. X., Rollin, L. M., Marcus, R. N., Sanchez, R., & Aripiprazole Study Group (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0414 · Cited by 290
Haloperidol alone or in combination for acute mania
Cipriani, A., Rendell, J. M., & Geddes, J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004362.pub2 · Cited by 285
Importance of Psychiatric Diagnosis in Prediction of Clinical Drug Effects
KLEIN, D. F. (1967) · Archives of General Psychiatry · doi:10.1001/archpsyc.1967.01730190120016 · Cited by 276
Hirschfeld, R. M. A., Keck, P. E., Kramer, M., Karcher, K., Canuso, C., Eerdekens, M., & Grossman, F. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.6.1057 · Cited by 273
Smith, L. A., Cornelius, V., Warnock, A., Tacchi, M. J., & Taylor, D. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00468.x · Cited by 270
Clozapine for treatment-refractory mania
(1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.6.759 · Cited by 265
Yatham, L. N., Kennedy, S. H., O'Donovan, C., Parikh, S. V., MacQueen, G., McIntyre, R. S., Sharma, V., Beaulieu, S., & for CANMAT guidelines group (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00432.x · Cited by 264 · cited 2×
“…2003a) were also considered (Zarin et al. 2002; Licht et al. 2003; Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Bipolar Disorder 2004; National Collaborating Centre for Mental Health 2006; Yatham et al. 2006; Jon et al. 2008; Nolen et al. 2008).”
BackgroundSachs, G., Chengappa, K., Suppes, T., Mullen, J., Brecher, M., Devine, N., & Sweitzer, D. (2004) · Bipolar Disorders · doi:10.1111/j.1399-5618.2004.00115.x · Cited by 262
Meehan, K., Zhang, F., David, S., Tohen, M., Janicak, P., Small, J., Koch, K., Rizk, R., Walker, D., Tran, P., et al. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200108000-00006 · Cited by 256
Sachs, G., Sanchez, R., Marcus, R., Stock, E., Mcquade, R., Carson, W., Abou-Gharbia, N., Impellizzeri, C., Kaplita, S., Rollin, L., et al. (2006) · Journal of Psychopharmacology · doi:10.1177/0269881106059693 · Cited by 251
Yatham, L. N., Grossman, F., Augustyns, I., Vieta, E., & Ravindran, A. (2003) · British Journal of Psychiatry · doi:10.1192/bjp.182.2.141 · Cited by 248 · cited 5×
“In comparison, patients with placebo experienced weight loss ( 0.25 kg) or gained weight to a maximum of 0.5 kg in both the studies in which risperidone has been combined with a mood stabilizer (Sachs et al. 2002; Yatham et al. 2003).”
BackgroundInfluentialSelf-citationElectroconvulsive Treatment Compared With Lithium in the Management of Manic States
Small, J. G. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800320037004 · Cited by 246
Prien, R. F. (1972) · Archives of General Psychiatry · doi:10.1001/archpsyc.1972.01750200050011 · Cited by 245
Scherk, H., Pajonk, F. G., & Leucht, S. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.4.442 · Cited by 243
Segal, J., Berk, M., & Brook, S. (1998) · PubMed · Cited by 238
A Double-Blind Randomized Pilot Study Comparing Quetiapine and Divalproex for Adolescent Mania
DELBELLO, M. P., KOWATCH, R. A., ADLER, C. M., STANFORD, K. E., WELGE, J. A., BARZMAN, D. H., NELSON, E., & STRAKOWSKI, S. M. (2006) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000194567.63289.97 · Cited by 234
Is Bipolar Disorder Overdiagnosed?
Zimmerman, M., Ruggero, C. J., Chelminski, I., & Young, D. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0608 · Cited by 230 · cited 1×
“Bipolar disorder is frequently misdiagnosed and under-diagnosed (Kasper et al. 2002; Angst 2006) although occasionally overdiagnosis may occur (Zimmerman et al. 2008).”
BackgroundEffect of sodium valproate on mania: The GABA-hypothesis of affective disorders
Emrich, H. M., Zerssen, D., Kissling, W., M�ller, H. J., & Windorfer, A. (1980) · Archiv f�r Psychiatrie und Nervenkrankheiten · doi:10.1007/bf00343800 · Cited by 230
Self-citationA 12-Week, Double-blind Comparison of Olanzapine vs Haloperidol in the Treatment of Acute Mania
Tohen, M., Goldberg, J. F., Gonzalez-Pinto Arrillaga, A. M., Azorin, J. M., Vieta, E., Hardy-Bayle, M.-C., Lawson, W. B., Emsley, R. A., Zhang, F., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.12.1218 · Cited by 229
Self-citationMcIntyre, R. S., Brecher, M., Paulsson, B., Huizar, K., & Mullen, J. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.02.006 · Cited by 227
Okuma, T., Inanaga, K., Otsuki, S., Sarai, K., Takahashi, R., Hazama, H., Mori, A., & Watanabe, M. (1979) · Psychopharmacology · doi:10.1007/bf00428308 · Cited by 223
Frances, R. J. (2007) · Yearbook of Psychiatry and Applied Mental Health · doi:10.1016/s0084-3970(08)70411-0 · Cited by 220
Yildiz, A., Guleryuz, S., Ankerst, D. P., Öngür, D., & Renshaw, P. F. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.43 · Cited by 213 · cited 1×
“On placebo-controlled, double blind study gave evidence for the antimanic efficacy of the protein kinase C inhibitor tamoxifen (Yildiz et al. 2008), although some methodological issues may raise concerns about the generalisability of the result (Tohen 2008).”
BackgroundSuppes, T., Mintz, J., McElroy, S. L., Altshuler, L. L., Kupka, R. W., Frye, M. A., Keck, P. E., Nolen, W. A., Leverich, G. S., Grunze, H., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.10.1089 · Cited by 209 · cited 2×
“Women appear more often affected than men, both in bipolar I (Arnold et al. 2000) and II disorder (Suppes et al. 2005).”
BackgroundSelf-citationEfficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study
Zarate, C. A., Singh, J. B., Carlson, P. J., Quiroz, J., Jolkovsky, L., Luckenbaugh, D. A., & Manji, H. K. (2007) · Bipolar Disorders · doi:10.1111/j.1399-5618.2007.00530.x · Cited by 208 · cited 2×
“2006; Hah and Hallmayer 2008) and one single blind study (Zarate et al. 2007) also found significant improvement of mania with tamoxifen.”
BackgroundAntimanic effect of clonazepam.
Chouinard, G., Young, S. N., & Annable, L. (1983) · PubMed · Cited by 201
Perlis, R. H., Welge, J. A., Vornik, L. A., Hirschfeld, R. M. A., & Keck, P. E. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0401 · Cited by 196
Smulevich, A. B., Khanna, S., Eerdekens, M., Karcher, K., Kramer, M., & Grossman, F. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2004.06.003 · Cited by 192
Cognitive-Behavioral Therapy for Bipolar Disorder
Basco, M. R., & Rush, A. J. (1996) · Cited by 191
Risperidone in the treatment of acute mania: Double-blind, placebo-controlled study
Khanna, S., Vieta, E., Lyons, B., Grossman, F., Eerdekens, M., & Kramer, M. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.187.3.229 · Cited by 188
Self-citationCarbamazepine Compared With Lithium in the Treatment of Mania
Small, J. G. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810340047006 · Cited by 186
THE NORTHWICK PARK "FUNCTIONAL" PSYCHOSIS STUDY: DIAGNOSIS AND TREATMENT RESPONSE
Johnstone, E., Frith, C., Crow, T., & Owens, D. C. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90682-4 · Cited by 186
Grunze, H., Kasper, S., Goodwin, G., Bowden, C., Baldwin, D., Licht, R., Vieta, E., Möller, H.-J., & WFSBP Task Force on Treatment Guide (2002) · The World Journal of Biological Psychiatry · doi:10.3109/15622970209150612 · Cited by 185 · cited 1×
“In contrast with the preceding WFSBP Bipolar Mania guidelines (Grunze et al. 2003a), but in line with the bipolar depression (Grunze et al. 2002) and maintenance treatment guideline (Grunze et al. 2004), this update is structured in terms of groups of medication rather than by subtypes of mania,…”
ResultSelf-citationThe Prospective Course of Rapid-Cycling Bipolar Disorder: Findings From the STEP-BD
Schneck, C. D., Miklowitz, D. J., Miyahara, S., Araga, M., Wisniewski, S., Gyulai, L., Allen, M. H., Thase, M. E., & Sachs, G. S. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.05081484 · Cited by 181
Kushner, S. F., Khan, A., Lane, R., & Olson, W. H. (2006) · Bipolar Disorders · doi:10.1111/j.1399-5618.2006.00276.x · Cited by 180
Correlates of antimanic response to carbamazepine
Post, R. M., Uhde, T. W., Roy-Byrne, P. P., & Joffe, R. T. (1987) · Psychiatry Research · doi:10.1016/0165-1781(87)90064-3 · Cited by 178
Treatment guidelines for bipolar disorder: A critical review
Fountoulakis, K. N., Vieta, E., Sanchez-Moreno, J., Kaprinis, S. G., Goikolea, J. M., & Kaprinis, G. S. (2005) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.01.004 · Cited by 177
Self-citationThe use of sodium valproate, carbamazepine and oxcarbazepine in patients with affective disorders
Emrich, H. M., Dose, M., & von Zerssen, D. (1985) · Journal of Affective Disorders · doi:10.1016/0165-0327(85)90022-9 · Cited by 176
Bipolar II Disorder: Epidemiology, Diagnosis and Management
Benazzi, F. (2007) · CNS Drugs · doi:10.2165/00023210-200721090-00003 · Cited by 175
Vieta, E., Bourin, M., Sanchez, R., Marcus, R., Stock, E., McQuade, R., Carson, W., Abou-Gharbia, N., Swanink, R., & Iwamoto, T. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.187.3.235 · Cited by 173
Self-citationKeck, P. E., Orsulak, P. J., Cutler, A. J., Sanchez, R., Torbeyns, A., Marcus, R. N., McQuade, R. D., & Carson, W. H. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.05.014 · Cited by 172
Lamotrigine: A Review of its Use in Bipolar Disorder
Goldsmith, D. R., Wagstaff, A. J., Ibbotson, T., & Perry, C. M. (2003) · Drugs · doi:10.2165/00003495-200363190-00009 · Cited by 171
Kupka, R. W., Luckenbaugh, D. A., Post, R. M., Suppes, T., Altshuler, L. L., Keck, P. E., Frye, M. A., Denicoff, K. D., Grunze, H., Leverich, G. S., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.7.1273 · Cited by 171
Self-citationMüller-Oerlinghausen, B., Retzow, A., Henn, F. A., Giedke, H., & Walden, J. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200004000-00012 · Cited by 170
Zajecka, J. M., Weisler, R., Sachs, G., Swann, A. C., Wozniak, P., & Sommerville, K. W. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1210 · Cited by 170
ECNP consensus meeting. Bipolar depression. Nice, March 2007
Goodwin, G. M., Anderson, I. M., Arango, C., Bowden, C. L., Henry, C., Mitchell, P. B., Nolen, W. A., Vieta, E., & Wïttchen, H. (2008) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.03.003 · Cited by 170
Self-citationYatham, L. N., Paulsson, B., Mullen, J., & Vågerö, A. M. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000144887.66319.2f · Cited by 168
Grunze, H., Kasper, S., Goodwin, G., Bowden, C., Baldwin, D., Licht, R. W., Vieta, E., & Möller, H.-J. (2003) · The World Journal of Biological Psychiatry · doi:10.3109/15622970309167904 · Cited by 167
Self-citationAder, M., Kim, S. P., Catalano, K. J., Ionut, V., Hucking, K., Richey, J. M., Kabir, M., & Bergman, R. N. (2005) · Diabetes · doi:10.2337/diabetes.54.3.862 · Cited by 166
Sources of lithium resistance in mixed mania.
Himmelhoch, J. M., & Garfinkel, M. E. (1986) · PubMed · Cited by 165
Anticonvulsants in affective disorders
Emrich, H. M., 大熊, 輝., & Müller, A. A. (1984) · Excerpta Medica eBooks · Cited by 165
Olanzapine compared to lithium in mania: a double-blind randomized controlled trial
Berk, M., Ichim, L., & Brook, S. (1999) · International Clinical Psychopharmacology · doi:10.1097/00004850-199911000-00003 · Cited by 165
Goodwin, G. M. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.164.2.149 · Cited by 162
Self-citationWeisler, R. H., Keck, P. E., Swann, A. C., Cutler, A. J., Ketter, T. A., Kalali, A. H., & SPD417 Study Group (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0308 · Cited by 162
Vieta, E., T’joen, C., McQuade, R. D., Carson, W. H., Marcus, R. N., Sanchez, R., Owen, R., & Nameche, L. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.07101560 · Cited by 161
Self-citationPotkin, S. G., Keck, P. E., Segal, S., Ice, K., & English, P. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000169068.34322.70 · Cited by 159
Shopsin, B. (1975) · Archives of General Psychiatry · doi:10.1001/archpsyc.1975.01760190036004 · Cited by 159
Grunze, H., Kasper, S. F., Goodwin, G. M., Bowden, C. L., ller, H.-J. R. M., & WFSBP Task Force on Treatment Guide (2004) · The World Journal of Biological Psychiatry · doi:10.1080/15622970410029924 · Cited by 159
Self-citationClozapine in the Treatment of Refractory Psychotic Mania
Green, A. I., Tohen, M., Patel, J. K., Banov, M. D., DuRand, C. J., Berman, I., Chang, H., Zarate, C. A., Posener, J. A., Lee, H., et al. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.6.982 · Cited by 151
Tardive dyskinesia in affective disorders.
Kane, J. M. (1999) · PubMed · Cited by 150
Carbamazepine and Haloperidol v Placebo and Haloperidol in Excited Psychoses
Klein, E. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790130061009 · Cited by 150
The economic burden of bipolar disease.
Woods, S. W. (2000) · PubMed · Cited by 149
Carbamazepine vs Lithium in the Treatment and Prophylaxis of Mania
Lusznat, R. M., Murphy, D. P., & Nunn, C. (1988) · The British Journal of Psychiatry · doi:10.1192/bjp.153.2.198 · Cited by 146
Ōkuma, T., Kishimoto, A., Inoue., M. D. K., Hisashi, M., Atsushi, O., Matsushita, T., Nakao, T., & Ogura, C. (1973) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1973.tb02661.x · Cited by 146
Zarate, C. A., & Tohen, M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.169 · Cited by 144
Bowden, C. L., Swann, A. C., Calabrese, J. R., Rubenfaer, L. M., Wozniak, P. J., Collins, M. A., Abi-Saab, W., Saltarelli, M., & Depakote ER Mania Study Group (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1003 · Cited by 142
Self-citationPlacidi, G. F., Lenzi, A., Lazzerini, F., Cassano, G., & Akiskal, H. S. (1986) · PubMed · Cited by 142
Valproate oral loading in the treatment of acute mania.
Keck, P. E., McElroy, S. L., Tuğrul, K., & Bennett, J. A. (1993) · PubMed · Cited by 138
Pattern of Response to Divalproex, Lithium, or Placebo in Four Naturalistic Subtypes of Mania
Swann, A. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00390-6 · Cited by 137 · cited 4×
“Based on secondary analyses from the comparative trials with olanzapine and the comparative trial with lithium and placebo by Bowden and co-workers (Bowden et al. 1994; Swann et al. 2002) and the study by McElroy et al.”
BackgroundMethodResultInfluentialSafety and Tolerability of Oral Loading Divalproex Sodium in Acutely Manic Bipolar Patients
Hirschfeld, R. M. A., Allen, M. H., McEvoy, J. P., Keck, P. E., & Russell, J. M. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n1202 · Cited by 134
McElroy, S. L., Keck, P. E., Stanton, S. P., Tugrul, K. C., Bennett, J. A., & Strakowski, S. M. (1996) · PubMed · Cited by 133
The risk of suicide in patients with bipolar disorders.
Simpson, S. G., & Jamison, K. R. (1999) · PubMed · Cited by 132
Valproate for acute mood episodes in bipolar disorder
Macritchie, K., Geddes, J. R., Scott, J. L., Haslam, D. R. S., de Lima, M. S., & Goodwin, G. M. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004052 · Cited by 129
Self-citationComparative Effects of Lithium and Chlorpromazine in the Treatment of Acute Manic States
Johnson, G., Gershon, S., Burdock, E. I., Floyd, A., & HEKIMIAN, L. J. (1971) · The British Journal of Psychiatry · doi:10.1192/bjp.119.550.267 · Cited by 129
Vasudev, K., Goswami, U., & Kohli, K. (2000) · Psychopharmacology · doi:10.1007/s002130000380 · Cited by 124
Allen, M. H., Hirschfeld, R. M., Wozniak, P. J., Baker, P. D., & Bowden, C. L. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.2.272 · Cited by 124
Self-citationClozapine in the treatment of dysphoric mania
Suppes, T. M., McElroy, S. L., Gilbert, J. M., Dessain, E. C., & Cole, J. O. (1992) · Biological Psychiatry · doi:10.1016/0006-3223(92)90108-c · Cited by 123
Carbamazepine versus lithium in mania: a double-blind study.
Lerer, B., Moore, N. C., Meyendorff, E., Cho, S. R., & Gershon, S. (1987) · PubMed · Cited by 123
Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants
Ghaemi, S. N., Hsu, D. J., Thase, M. E., Wisniewski, S. R., Nierenberg, A. A., Miyahara, S., & Sachs, G. (2006) · Psychiatric Services · doi:10.1176/appi.ps.57.5.660 · Cited by 121
Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics
Frye, M. A., Ketter, T. A., Altshuler, L. L., Denicoff, K., Dunn, R. T., Kimbrell, T. A., Corá-Locatelli, G., & Post, R. M. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(97)00160-2 · Cited by 119
Kulkarni, J., Garland, K. A., Scaffidi, A., Headey, B., Anderson, R., de Castella, A. R., Fitzgerald, P. B., & Davis, S. R. (2005) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2005.11.001 · Cited by 118
Reproductive function and risk for PCOS in women treated for bipolar disorder
Rasgon, N., Altshuler, L. L., Fairbanks, L. A., Elman, S., Bitran, J. A., Labarca, R., Saad, M. F., Kupka, R., Nolen, W. A., Frye, M. A., et al. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00201.x · Cited by 118
Self-citationMorselli, P. L., Elgie, R., & Cesana, B. (2004) · Bipolar Disorders · doi:10.1111/j.1399-5618.2004.00160.x · Cited by 117
Calcium antagonists in mania: A double-blind study of verapamil
Dubovsky, S. L., Franks, R. D., Allen, S., & Murphy, J. R. (1986) · Psychiatry Research · doi:10.1016/0165-1781(86)90016-8 · Cited by 116
Phenytoin as an Antimanic Anticonvulsant: A Controlled Study
Mishory, A., Yaroslavsky, Y., Bersudsky, Y., & Belmaker, R. H. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.3.463 · Cited by 116
Lamotrigine Compared with Lithium in Mania: A Double-Blind Randomized Controlled Trial
Ichim, L., Berk, M., & Brook, S. (2000) · Annals of Clinical Psychiatry · doi:10.1023/a:1009066725103 · Cited by 114
Penrsistent Tardive Dyskinesia in Bipolar Patients
Mukherjee, S., ROSEN, A. C., Caracci, G., & Shukla, S. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800040052008 · Cited by 113
Okuma, T., Yamashita, I., Takahashi, R., Itoh, H., Otsuki, S., Watanabe, S., Sarai, K., Hazama, H., & Inanaga, K. (1990) · Pharmacopsychiatry · doi:10.1055/s-2007-1014497 · Cited by 113
A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania
Garfinkel, P. E., Stancer, H. C., & Persad, E. (1980) · Journal of Affective Disorders · doi:10.1016/0165-0327(80)90029-4 · Cited by 112
van Winkel, R., Binder, M. D., Wampers, M., Eyck, D. V., Hanssens, L., Scheen, A. J., & Peuskens, J. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0320 · Cited by 109
Young, A. H., Oren, D. A., Lowy, A., McQuade, R. D., Marcus, R. N., Carson, W. H., Spiller, N. H., Torbeyns, A. F., & Sanchez, R. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.049965 · Cited by 109
Acute bipolar mania: a systematic review and meta‐analysis of co‐therapy vs. monotherapy
Smith, L. A., Cornelius, V. R., Warnock, A., Tacchi, M. J., & Taylor, D. M. (2006) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2006.00912.x · Cited by 104
Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia.
Keck, P. E., McElroy, S. L., Strakowski, S. M., & Soutullo, C. A. (2000) · PubMed · Cited by 103
Combined Chlorpromazine and Electroconvulsive Therapy in Mania
Sikdar, S., Kulhara, P., Avasthi, A., & Singh, H. (1994) · British Journal of Psychiatry · doi:10.1192/bjp.164.6.806 · Cited by 101 · cited 1×
“In the other prospective study, combined treatment with ECT and chlorpromazine was more effective than chlorpromazine alone (Sikdar et al. 1994).”
ResultMolecular genetics of bipolar disorder
Hayden, E. P., & Nurnberger, J. I. (2006) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2005.00138.x · Cited by 101
Adjunctive treatment of manic agitation with lorazepam versus haloperidol: a double-blind study.
Lenox, R. H., NEWHOUSE, P. A., Creelman, W., & Whitaker, T. M. (1992) · PubMed · Cited by 99
A review of the evidence for carbamazepine and oxcarbazepine in the treatment of bipolar disorder
Hirschfeld, R. M. A., & Kasper, S. F. (2004) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004651 · Cited by 98
Self-citationThe first open study of zonisamide, a novel anticonvulsant, shows efficacy in mania
Kanba, S., Yagi, G., Kamijima, K., Toru, S., Tajima, O., Jun-Ichi, O., Eiji, A., Koshikawa, H., Nibuya, M., Kinoshita, N., et al. (1994) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(94)90078-7 · Cited by 98
Commercial influence and the content of medical journals
Lexchin, J., & Light, D. W. (2006) · BMJ · doi:10.1136/bmj.332.7555.1444 · Cited by 97
Olanzapine Versus Risperidone in the Treatment of Manic or Mixed States in Bipolar I Disorder
Perlis, R. H., Baker, R. W., Zarate, C. A., Brown, E. B., Schuh, L. M., Jamal, H. H., & Tohen, M. F. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1112 · Cited by 95
Regeer, E. J., Ten Have, M., Rosso, M. L., Hakkaart‐van Roijen, L., Vollebergh, W., & Nolen, W. A. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00363.x · Cited by 93
Maina, G., Albert, U., Bellodi, L., Colombo, C., Faravelli, C., Monteleone, P., Bogetto, F., Cassano, G. B., & Maj, M. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0205 · Cited by 92 · cited 2×
“Particularly when unrecognised or misdiagnosed, and consequently ineffectively treated, bipolar disorder constitutes a devastating illness (Simpson and Jamison 1999; Morselli et al. 2004; Maina et al. 2007) with a significant socioeconomic burden (Woods 2000; Angst 2004; van Hakkaart et al.”
BackgroundValproate in bipolar disorder: 2000 onwards
Bowden, C. L., & Singh, V. K. (2005) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2005.00522.x · Cited by 92
Self-citationPolytherapy in Bipolar Disorder
Lin, D., Mok, H., & Yatham, L. N. (2006) · CNS Drugs · doi:10.2165/00023210-200620010-00003 · Cited by 91 · cited 1×
“Clinical routine appears to be based on polypharmacy in bipolar patients (Lin et al. 2006; Ghaemi et al. 2006; Wolfsperger et al. 2007; Peh and Tay 2008).”
BackgroundA Comparison of Lithium Carbonate and Chlorpromazine in Mania
Platman, S. R. (1970) · American Journal of Psychiatry · doi:10.1176/ajp.127.3.351 · Cited by 90
Australian and New Zealand clinical practice guidelines for the treatment of bipolar disorder
Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines Team for Bipolar Disorder (2004) · Australian and New Zealand Journal of Psychiatry · doi:10.1111/j.1440-1614.2004.01356.x · Cited by 90
Tohen, M., Vieta, E., Goodwin, G. M., Sun, B., Amsterdam, J. D., Banov, M., Shekhar, A., Aaronson, S. T., Bardenstein, L., Grecu-Gabos, I., et al. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n1113 · Cited by 87
Self-citationRight prefrontal TMS versus sham treatment of mania: a controlled study
Kaptsan, A., Yaroslavsky, Y., Applebaum, J., Belmaker, R., & Grisaru, N. (2003) · Bipolar Disorders · doi:10.1034/j.1399-5618.2003.00003.x · Cited by 87
Ziprasidone for Schizophrenia and Bipolar Disorder: A Review of the Clinical Trials
Greenberg, W. M., & Citrome, L. (2007) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2007.00008.x · Cited by 87
Hirschfeld, R. M. A., Baker, J. D., Wozniak, P., Tracy, K. A., & Sommerville, K. W. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0717 · Cited by 87
Licht, R. W., Vestergaard, P., Kessing, L. V., Larsen, J. K., & Thomsen, P. H. (2003) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.108.s419.1.x · Cited by 85
Self-citationRole of risperidone in bipolar II: an open 6-month study
Vieta, E., Gastó, C., Colom, F., Reinares, M., Martínez‐Arán, A., Benabarre, A., & Akiskal, H. S. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00435-9 · Cited by 83
Self-citationRoijen, L. H., Hoeijenbos, M., Regeer, E. J., ten Have, M., Nolen, W. A., Veraart, C. P. W. M., & Rutten, F. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2004.00403.x · Cited by 83
A meta-analysis of the use of typical antipsychotic agents in bipolar disorder
Tohen, M. F., Zhang, F., Taylor, C. C., Burns, P., Zarate, C. A., Sanger, T. M., & Tollefson, G. D. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00162-2 · Cited by 82
Hiremani, R. M., Thirthalli, J., Tharayil, B. S., & Gangadhar, B. N. (2008) · Bipolar Disorders · doi:10.1111/j.1399-5618.2008.00608.x · Cited by 79 · cited 1×
“Recent work suggests that bifrontal ECT is at least as efficacious as bitemporal ECT in severe mania and better tolerated (Hiremani et al. 2008; Barekatain et al. 2008).”
BackgroundGu, N., Tohen, M. F., Qiuqing, A., Fude, Y., Pope, E., McElroy, H. J., Li, M., Gaohua, W., Xinbao, Z., Li, H., et al. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.04.020 · Cited by 79
Mania, psychosis, and antipsychotics.
McElroy, S. L., Keck, P. E., & Strakowski, S. M. (1996) · PubMed · Cited by 78
Open-Label Adjunctive Zonisamide in the Treatment of Bipolar Disorders
McElroy, S. L., Suppes, T. M., Keck, P. E., Black, D., Frye, M. A., Altshuler, L. L., Nolen, W. A., Kupka, R., Leverich, G. S., Walden, J., et al. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0512 · Cited by 78
Self-citationDifferential olanzapine plasma concentrations by sex in a fixed-dose study
Kelly, D. L., Conley, R. R., & Tamminga, C. A. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00053-5 · Cited by 78
Generalisability of results from randomised drug trials: A trial on antimanic treatment
Licht, R. W., Gouliaev, G., Vestergaard, P., & Frydenberg, M. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.170.3.264 · Cited by 78
Self-citationInfluence of sub-syndromal symptoms after remission from manic or mixed episodes
Tohen, M., Bowden, C. L., Calabrese, J. R., Lin, D., Forrester, T. D., Sachs, G. S., Koukopoulos, A., Yatham, L., & Grunze, H. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.bp.105.020321 · Cited by 78
Self-citationBlack, D. W., Winokur, G., & Nasrallah, A. T. (1987) · PubMed · Cited by 78
Tiagabine in treatment refractory bipolar disorder: a clinical case series
Suppes, T. M., Chisholm, K., Dhavale, D. M., Frye, M. A., Altshuler, L. L., McElroy, S. L., Keck, P. E., Nolen, W. A., Kupka, R., Denicoff, K. D., et al. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01201.x · Cited by 77
Vieta, E., Ramey, T. S., Keller, D., English, P., Loebel, A. D., & Miceli, J. J. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881108099418 · Cited by 76
Self-citationOlanzapine plus carbamazepinev.carbamazepine alone in treating manic episodes
Tohen, M. F., Bowden, C. L., Ab, S., Bergstrom, R. F., Quinlan, T., Osuntokun, O. O., Wang, W. V., Oliff, H. S., Martényi, F., Kryzhanovskaya, L. A., et al. (2008) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.041301 · Cited by 75
Self-citationDiagnosis and treatment of mixed mania
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.1.96 · Cited by 75
Yatham, L. N., Vieta, E., Young, A. H., Möller, H., Paulsson, B., & Vågerö, M. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e328080ca57 · Cited by 73
Self-citationChouinard, G., Annable, L., Turnier, L., Holobow, N. E., & Szkrumelak, N. (1993) · PubMed · Cited by 73
Vieta, E., Calabrese, J. R., Hennen, J. A., Colom, F., Martínez‐Arán, A., Sánchez‐Moreno, J., Yatham, L. N., Tohen, M. F., & Baldessarini, R. J. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n1019 · Cited by 72
Self-citationDouble-Blind Comparison of the Effects of Clonazepam and Lorazepam in Acute Mania
Bradwejn, J., Shriqui, C. L., Koszycki, D., & Meterissian, G. B. (1990) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199010060-00004 · Cited by 72
Verapamil for the Treatment of Acute Mania: A Double-Blind, Placebo-Controlled Trial
Janicak, P. G., Sharma, R. P., Pandey, G., & Davis, J. M. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.7.972 · Cited by 69
Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004
Wolfsperger, M., Greil, W., Wulf Rössler, A., & Grohmann, R. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2006.08.017 · Cited by 69
Tardive dyskinesia: eliminated, forgotten, or overshadowed?
Remington, G. J. (2007) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328017f6b1 · Cited by 68
Levetiracetam in the Treatment of Acute Mania
Grunze, H., Langosch, J. M., Born, C., Schaub, G., & Walden, J. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0707 · Cited by 67
Self-citationDo Many Patients with Depression Suffer from Bipolar Disorder?
Angst, J. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605100102 · Cited by 66
The role of gender in mixed mania
Arnold, L. M., McElroy, S. L., & Keck, P. E. (2000) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(00)90137-8 · Cited by 66
Acute Dysphoric Mania: Treatment Response to Olanzapine Versus Placebo
Baker, R. W., Tohen, M. F., FAWCETT, J. A., Risser, R. C., Schuh, L. M., Brown, E., Stauffer, V. L., Shao, L., & Tollefson, G. D. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200304000-00005 · Cited by 65
Intravenous Valproate Loading in Acutely Manic and Depressed Bipolar I Patients
Grunze, H., Erfurth, A., Amann, B. L., Giupponi, G., Kammerer, C., & Walden, J. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199908000-00003 · Cited by 61
Self-citationThomas, J., & Reddy, B. (1982) · Journal of Affective Disorders · doi:10.1016/0165-0327(82)90038-6 · Cited by 60
Antonini, A., Abbruzzese, G., Barone, P., Bonuccelli, U., Lopiano, L., Onofrj, M., Zappia, M., & Quattrone, A. (2008) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s2404 · Cited by 60
Open Trial of a Calcium Antagonist, Nimodipine, in Acute Mania
Brunet, G., Cerlich, B., Robert, P. H., Dumas, S., Souêtre, E., & DARCOURT, G. (1990) · Clinical Neuropharmacology · doi:10.1097/00002826-199006000-00004 · Cited by 60
Treatment of mania, mixed state, and rapid cycling.
Kusumakar, V., Yatham, L. N., Haslam, D. R. S., Parikh, S. V., Matte, R., Silverstone, P. H., & Sharma, V. (1997) · PubMed · Cited by 59
Efficacy of olanzapine combined with valproate or lithium in the treatment of dysphoric mania
Baker, R. W., Brown, E., Akiskal, H. S., Calabrese, J. R., Ketter, T. A., Schuh, L. M., Trzepacz, P. T., Watkin, J. G., & Tohen, M. F. (2004) · The British Journal of Psychiatry · doi:10.1192/bjp.185.6.472 · Cited by 59
Goldberg, J. F., & Burdick, K. E. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.148 · Cited by 57
Lithium combined with carbamazepine or haloperidol in the treatment of mania.
Small, J. G., Klapper, M. H., Marhenke, J. D., Milstein, V., Woodham, G. C., & Kellams, J. J. (1995) · PubMed · Cited by 56
Carbamazepine Compared to Haloperidol in Acute Mania
BROWN, D., Silverstone, T., & Cookson, J. (1989) · International Clinical Psychopharmacology · doi:10.1097/00004850-198907000-00005 · Cited by 55
Bifrontal Versus Bitemporal Electroconvulsive Therapy in Severe Manic Patients
Barekatain, M., Jahangard, L., Haghighi, M., & Ranjkesh, F. (2008) · The Journal of ECT · doi:10.1097/yct.0b013e3181624b5d · Cited by 54 · cited 1×
“Recent work suggests that bifrontal ECT is at least as efficacious as bitemporal ECT in severe mania and better tolerated (Hiremani et al. 2008; Barekatain et al. 2008).”
BackgroundECT versus chlorpromazine in mania.
McCabe, M., & Norris, B. (1977) · PubMed · Cited by 54
Cognitive-behavioral therapy for bipolar disorder
MacKenzie, K. (1997) · General Hospital Psychiatry · doi:10.1016/s0163-8343(97)00003-0 · Cited by 54
Bipolar disorder in neurologic illness
Schneck, C. D. (2002) · Current Treatment Options in Neurology · doi:10.1007/s11940-002-0015-3 · Cited by 53
Clonazepam in Acute Mania: A Double Blind Trial
Edwards, R. A., Stephenson, U., & Flewett, T. (1991) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048679109077740 · Cited by 52
Whitlock, F. A., & Evans, L. (1978) · Drugs · doi:10.2165/00003495-197815010-00004 · Cited by 51
Acute Mania: Haloperidol Dose and Augmentation With Lithium or Lorazepam
Chou, J. C.-Y., Czobor, P., Charles, O., Tuma, I., Winsberg, B. G., Allen, M. H., Trujillo, M., & Volavka, J. (1999) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199912000-00003 · Cited by 51
Superiority of Lithium Over Verapamil in Mania
Walton, S. A., Berk, M., & Brook, S. (1996) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v57n1108 · Cited by 50
Plasma concentrations of high‐dose olanzapine in a double‐blind crossover study
Kelly, D. L., Richardson, C. M., Yu, Y., & Conley, R. R. (2006) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.781 · Cited by 48
Cited by
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011
Hiemke, C., Baumann, P., Bergemann, N., Conca, A., Dietmaier, O., Egberts, K., Fric, M., Gerlach, M., Greiner, C., Gründer, G., et al. (2011) · Pharmacopsychiatry · doi:10.1055/s-0031-1286287 · Cited by 868
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
“Furthermore, even between episodes of illness, individuals with mood disorders often continue to suffer subthreshold depressive symptoms, which can compromise their quality of life, limit functioning and increase the risk of relapse (Grunze et al., 2009).”
BackgroundHasan, A., Falkai, P., Wobrock, T., Lieberman, J., Glenthoj, B., Gattaz, W. F., Thibaut, F., Möller, H.-J., & the Wfsbp Task Force on Treatment Guidelines for Schizophrenia (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2012.696143 · Cited by 637
Self-citationBauer, M., Pfennig, A., Severus, E., Whybrow, P. C., Angst, J., Möller, H.-J., & Šon behalf of the Task Force on Unipolar Depressive Disorders (2013) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2013.804195 · Cited by 632
“According to Bandelow et al. (2008) and Grunze et al. (2009), six categories of evidence (CE A to F) were used: CE A: Full evidence from controlled trials CE B: Limited positive evidence from controlled trials CE C: Evidence from uncontrolled studies or case reports/expert opinion CE D:…”
MethodSelf-citationCipriani, A., Barbui, C., Salanti, G., Rendell, J., Brown, R., Stockton, S., Purgato, M., Spineli, L. M., Goodwin, G. M., & Geddes, J. R. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60873-8 · Cited by 631
Self-citation
Metadata
- Authors
- Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., WFSBP Task Force on Treatment Guide, Grunze, H., Vieta, E., Goodwin, G. M., Bowden, C., Licht, R. W., Möller, H.-J., Kasper, S., & WFSBP Task Force on Treatment Guide
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2009-01
- Volume
- 10
- Issue
- 2
- Pages
- 85-116
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W2139073163
- Cited by
- 346
- References
- 257
- FWCI
- 19.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.